Clinical Trial Update: Development of Circulating Tumour Cell Molecular Diagnostics Using a Novel Microfluidic Device

View source ↗

Summary

Progress update on developing a circulating tumor cell molecular diagnostic using a novel microfluidic device for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Patients With Non-small Cell Lung Cancer | Status: UNKNOWN